Interventional Neuroradiology Market Report 2026

The interventional neuroradiology market size has grown strongly in recent years. It will grow from $2.05 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to increasing prevalence of cerebral aneurysms and stroke, advancements in medical imaging technologies, limitations of open neurosurgical procedures, growing availability of trained interventional specialists, expansion of neurovascular care infrastructure.

The interventional neuroradiology market size is expected to see strong growth in the next few years. It will grow to $2.73 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rising global burden of neurological disorders, increasing adoption of flow diversion and embolization technologies, growing demand for faster stroke intervention, technological advancements in microcatheters and guidewires, expanding investments in neurointerventional research. Major trends in the forecast period include growing preference for minimally invasive neurovascular procedures, rising adoption of endovascular treatment for acute stroke, expansion of advanced neurovascular device portfolios, increasing focus on improved procedural precision and safety, growth in specialized interventional neuroradiology centers.

The increasing prevalence of neurological disorders is expected to drive the growth of the interventional neuroradiology market in the coming years. Neurological disorders are medical conditions that impact the brain, spinal cord, or peripheral nerves, affecting movement, sensation, cognition, or communication. The rise in neurological disorders is attributed to the aging global population, which increases the risk of age-related conditions such as Alzheimer's, as well as advancements in diagnostic technologies that enable earlier and more precise detection of these disorders. Interventional neuroradiology addresses neurological disorders through minimally invasive, image-guided techniques used to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For example, in October 2023, the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, reported that over 40% of the global population was living with a neurological condition, and the overall burden of neurological diseases was expected to nearly double by 2050. Consequently, the rising prevalence of neurological disorders is fueling the growth of the interventional neuroradiology market.

Major companies operating in the interventional neuroradiology market are emphasizing the development of technologically advanced solutions, such as head immobilizers designed to improve imaging quality and patient safety during interventional radiology and neuroradiology procedures. A head immobilizer is a medical device intended to temporarily stabilize a patient's head and neck, primarily to ensure safety and stability in cases of suspected head or spinal injury. For example, in June 2023, Adept Medical, a New Zealand-based medical device manufacturer, introduced a new head immobilizer designed to enhance patient comfort and imaging quality during interventional radiology and neuroradiology procedures. This innovative device incorporates vacuum suction technology for secure head fixation, a radiolucent design that reduces interference with X-ray imaging, and compatibility with various imaging tables. Its quick setup process streamlines workflows, while its ability to accommodate different head shapes ensures patient comfort.

In January 2023, GE Healthcare Technologies Inc., a US-based healthcare company, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE Healthcare intends to strengthen its interventional guidance offerings with CT-Navigation technology, improving procedural accuracy, reducing variability, and expanding capabilities in interventional radiology while scaling IMACTIS's solutions across medical fields. IMACTIS is a France-based medical technology company specializing in computed tomography navigation systems.

Major companies operating in the interventional neuroradiology market are Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, Medico's Hirata Inc.

North America was the largest region in the interventional neuroradiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional neuroradiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the interventional neuroradiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the interventional neuroradiology market by increasing costs of imported neurovascular devices, imaging components, and precision manufacturing inputs. These impacts are most evident in microcatheters, embolic coils, and flow diversion device segments, particularly across asia-pacific and europe where device sourcing is globally distributed. Higher tariffs have increased procurement costs for hospitals and ambulatory surgical centers. However, tariffs are also encouraging domestic manufacturing, regional supplier development, and innovation in cost-optimized neurointerventional devices, supporting long-term market resilience.

The interventional neuroradiology market research report is one of a series of new reports that provides interventional neuroradiology market statistics, including interventional neuroradiology industry global market size, regional shares, competitors with a interventional neuroradiology market share, detailed interventional neuroradiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neuroradiology industry. This interventional neuroradiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Interventional neuroradiology (INR) is a specialized branch of medicine that focuses on minimally invasive techniques to diagnose and treat various neurological disorders affecting the brain, spine, and blood vessels. It utilizes advanced imaging technologies to guide procedures such as catheter-based interventions, angioplasties, stent placements, and embolization.

The primary types of devices used in interventional neuroradiology include microcatheters, neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, and micro guidewires. Microcatheters are thin, flexible tubes designed to navigate the intricate and small blood vessels of the brain and spine during interventional procedures. They are employed for a variety of conditions, including cerebral aneurysms, intracranial tumors, acute strokes, and more, serving diverse end users such as hospitals, ambulatory surgical centers, and diagnostic centers.

The interventional neuroradiology market consists of revenues earned by entities by providing services such as embolization procedures, balloon angioplasty, endovascular coiling, and mechanical thrombectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional neuroradiology market also includes sales of embolization agents, guidewires, microsurgical instruments, and neurovascular catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.